Log in
Enquire now
‌

US Patent 10751345 Combination therapy with apilimod and glutamatergic agents

Patent 10751345 was granted and assigned to OrphAI Therapeutics on August, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 10751345 Combination therapy with apilimod and glutamatergic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.